{
  "meta": {
    "title": "Reciprocal_Regulation",
    "url": "https://brainandscalpel.vercel.app/reciprocal-regulation-e8fb1b6c.html",
    "scrapedAt": "2025-11-29T18:23:15.955Z"
  },
  "questions": [
    {
      "id": 6415,
      "choices": [
        {
          "id": 25629,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It prevents lipolysis by inhibiting the activity of hormone sensitive lipase</span></span></span></p>"
        },
        {
          "id": 25630,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It stimulates glycogenolysis</span></span></span></p>"
        },
        {
          "id": 25631,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It increases proteins synthesis and prevents protein breakdown </span></span></span></p>"
        },
        {
          "id": 25632,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It decreases gluconeogenesis in cells</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding the metabolic effects of insulin, which of the following statements is INCORRECT?</span></span></span></p>",
      "unique_key": "Q6959425",
      "question_audio": null,
      "question_video": null,
      "map_id": 29930,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) It stimulates glycogenolysis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin </strong>is an <strong>anabolic hormone</strong> that promotes the <strong>storage of glucose, fatty acids, and amino acids</strong> in cells. Its actions are primarily directed towards<strong> lowering blood glucose levels</strong> and preventing the <strong>breakdown of stored energy.</strong> Specifically, <strong>insulin inhibits</strong> <strong>glycogenolysis</strong>, which is the<strong> breakdown of glycogen into glucose, not stimulates </strong>it. This is in line with <strong>insulin&#39;s overall</strong> role in <strong>reducing blood glucose levels</strong> by encouraging the <strong>storage of glucose </strong>in the form of <strong>glycogen in liver and muscle cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:16px\">other options:</span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It prevents lipolysis by inhibiting the activity of hormone-sensitive lipase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>true</strong>. <strong>Insulin inhibits</strong> <strong>hormone-sensitive lipase</strong> in adipose tissue, thereby <strong>reducing the breakdown of triglycerides</strong> into<strong> free fatty acids and glycerol,</strong> which is known as<strong> lipolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It increases protein synthesis and prevents protein breakdown:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>accurate</strong>.<strong> Insulin promotes</strong> the <strong>uptake of amino</strong> <strong>acids </strong>by <strong>cells </strong>and <strong>stimulates protein synthesis</strong> while<strong> inhibiting protein degradation</strong>, thus supporting <strong>anabolic processes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It decreases gluconeogenesis in cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>correct. Insulin</strong> <strong>inhibits gluconeogenesis</strong>, which is the generation of <strong>glucose from non-carbohydrate substrates,</strong> further contributing to the<strong> reduction of blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose Uptake</span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin </strong>facilitates diffusion of<strong> glucose in muscle. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transporter, <strong>GLUT-4 is insulin dependent</strong></span></span></span></li>\r\n</ul>\r\n\r\n<ol start=\"2\" style=\"list-style-type:decimal\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Utilization of Glucose</strong>: <strong>Glycolysis increased</strong> (key glycolytic enzymes: glucokinase, phosphofructokinase &amp; pyruvate kinase) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin</strong> favors<strong> storage of glucose:</strong> <strong>Glycogen synthesis increased</strong> (Glycogen synthase) (option B)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate&nbsp;&nbsp; dehydrogenase</strong> (NADPH) activity is enhanced by insulin.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-lipolytic effect: Hormone sensitive lipase</strong> is <strong>decreased</strong> (option A).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis Decreased</strong> (Key gluconeogenic enzymes: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Fructose 1,6-bisphosphatase and Glucose 6-phosphatase are inhibited by insulin. (option D)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-ketogenic Effect</strong>: <strong>HMG CoA synthase</strong> is <strong>decreased</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It<strong> increases proteins synthesis</strong> and<strong> prevents protein breakdown </strong></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p319-322.</span></strong></span></span></p>",
      "correct_choice_id": 25630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6452,
      "choices": [
        {
          "id": 25777,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased skeletal muscle glucose uptake</span></span></span></p>"
        },
        {
          "id": 25778,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased adipose lipogenesis</span></span></span></p>"
        },
        {
          "id": 25779,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased adipose lipolysis</span></span></span></p>"
        },
        {
          "id": 25780,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased skeletal muscle Glycogenolysis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with an established diagnosis of diabetes mellitus reports to the clinic for a follow-up, presenting with symptoms of fatigue, weight loss, polyuria, and a burning sensation in the soles. Despite ongoing treatment, his blood glucose levels are significantly elevated. Among the following options, which is LEAST likely to contribute to the hyperglycemia seen in uncontrolled Type 1 diabetes?</span></span></span><br />\r\n&nbsp;</p>",
      "unique_key": "Q9168923",
      "question_audio": null,
      "question_video": null,
      "map_id": 29932,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Increased skeletal muscle Glycogenolysis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of<strong> uncontrolled Type 1 diabetes, </strong>the primary <strong>metabolic</strong> disturbances include<strong> decreased glucose uptake by skeletal</strong> <strong>muscles due to the lack of insulin,</strong> and <strong>increased lipolysis</strong> in adipose tissue, contributing to<strong> hyperglycemia</strong>. While <strong>increased</strong> <strong>glycogenolysis in the liver</strong> can contribute to <strong>hyperglycemia </strong>by releasing <strong>more glucose into the bloodstream</strong>, <strong>increased skeletal</strong> <strong>muscle glycogenolysis</strong> is <strong>less</strong> likely to contribute directly to <strong>hyperglycemia.</strong> This is because<strong> glucose </strong>produced from <strong>glycogen</strong> <strong>breakdown</strong> in <strong>skeletal muscles</strong> is generally used <strong>within the muscle</strong> itself and<strong> does not</strong> significantly contribute to the <strong>systemic</strong> <strong>glucose pool,</strong> especially in the context of<strong> insulin deficiency </strong>where<strong> glucose uptake</strong> by<strong> muscles</strong> is already<strong> impaired.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased skeletal muscle glucose uptake</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a significant contributor to <strong>hyperglycaemia in Type 1 diabetes</strong>, as <strong>insulin deficiency prevents glucose</strong> from<strong> entering cells,</strong> leading to <strong>elevated blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased adipose lipogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>decreased formation of fat </strong>from glucose in adipose tissue could be observed in <strong>insulin deficiency,</strong> it&#39;s <strong>not</strong> a direct contributor to<strong> elevated glucose levels. Insulin </strong>promotes <strong>lipogenesis</strong>, so <strong>its deficiency</strong> would <strong>decrease </strong>this process, but this <strong>decrease does not </strong>directly cause <strong>hyperglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increased adipose lipolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Increased breakdown of fat </strong>in the <strong>absence of insulin</strong> action <strong>elevates free fatty acid levels,</strong> which can<strong> exacerbate insulin resistance </strong>and contribute to<strong> higher blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Skeletal muscle cannot </strong>export<strong> glucose</strong> into the circulation like <strong>liver</strong> due to <strong>absence</strong> of enzyme <strong>glucose-6-phosphatase. </strong>So, <strong>intramyocellular glycogen </strong>acts as a<strong> fuel source for skeletal muscle</strong> and <strong>doesn&rsquo;t </strong>contribute to the <strong>hyperglycaemia</strong> in <strong>uncontrolled</strong> <strong>type I diabetes. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasons of<strong> hyperglycemia </strong>associated with<strong> uncontrolled type I diabetes:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There will be <strong>decreased insulin mediated glucose</strong> utilization by <strong>skeletal muscle and adipose tissues </strong>&rarr; will contribute to <strong>hyperglycaemia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There will also be<strong> decreased insulin-mediated suppression </strong>of <strong>hepatic glucose output. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased insulin-mediated suppression of lipolysis</strong> &rarr; <strong>hyperglycaemia</strong>, by<strong> activation of gluconeogenesis</strong> by<strong> fatty acid breakdown product acetyl CoA</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 149, DM Vasudevan, 9/e: p 323-326.</span></strong></span></span></p>",
      "correct_choice_id": 25780,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6407,
      "choices": [
        {
          "id": 25597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased lipolysis</span></span></span></p>"
        },
        {
          "id": 25598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased protein catabolism </span></span></span></p>"
        },
        {
          "id": 25599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased hepatic Glucose output</span></span></span></p>"
        },
        {
          "id": 25600,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase glucose uptake</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 39-year-old female presents with weight loss, fatigue, nocturia, and excessive thirst. Laboratory findings reveal fasting blood sugar (FBS) &gt;140 mg/dl and postprandial blood sugar (PPBS) &gt;250 mg/dl, leading to a probable diagnosis of Type 1 diabetes mellitus. Considering the pathophysiology of Type 1 diabetes mellitus, which of the following statements is TRUE?</span></span></span></p>",
      "unique_key": "Q5085657",
      "question_audio": null,
      "question_video": null,
      "map_id": 29928,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Increased lipolysis&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> poorly controlled type 1 diabetes mellitus</strong>, the patient is<strong> hyperglycemic</strong>, due to l<strong>ack of insulin to stimulate uptake </strong>and <strong>utilization of glucose </strong>and<strong> no insulin </strong>to antagonize the actions of glucagon, there is <strong>increased gluconeogenesis </strong>from <strong>amino acids </strong>in the liver.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lack of insulin </strong>to <strong>antagonize the actions of glucagon </strong>results in <strong>increased lipolysis </strong>in adipose tissue, and the resultant <strong>NEFAs </strong>are<strong> substrates for ketogenesis </strong>in the<strong> liver. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Utilization</strong> of the <strong>ketone bodies</strong> in <strong>muscle (and other tissues) </strong>may be <strong>impaired </strong>because of the <strong>lack of oxaloacetate </strong>&rarr;&nbsp; <strong>Diabetic ketoacidosis </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coma </strong>results from <strong>acidosis and increased osmolality </strong>of extracellular fluid </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Decreased protein catabolism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Insulin </strong>is an <strong>anabolic hormone</strong>, it promotes <strong>protein synthesis </strong>and <strong>its degradation </strong>is <strong>retarded</strong>. So, in <strong>its deficiency </strong>the effect is<strong> reversed</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased hepatic Glucose output:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In<strong> muscles</strong>, the <strong>glucose transporter GLUT4 </strong>is <strong>decreased, </strong>but in <strong>liver the glucose uptake </strong>is by <strong>GLUT2 </strong>which is <strong>independent of insulin</strong>. In <strong>absence of insulin Glycolysis is inhibited, Gluconeogenesis is favoured </strong>and G<strong>lycogen synthesis and storage </strong>is <strong>not favoured. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; Increase glucose uptake:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Due to <strong>lack of insulin</strong>, <strong>no stimulation of uptake </strong>and <strong>utilization of glucose</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type 1 diabetes mellitus </strong>is characterized by an <strong>autoimmune destruction of pancreatic &beta;-cells</strong>, leading to <strong>absolute insulin deficiency</strong>. <strong>Insulin </strong>normally <strong>inhibits lipolysis</strong>, so its <strong>deficiency in Type 1 diabetes </strong>results in <strong>increased lipolysis in adipose tissue</strong>. This leads to <strong>elevated levels </strong>of <strong>free fatty acids </strong>in the bloodstream, which can contribute to the production of<strong> ketone bodies in the liver, </strong>a <strong>common complication </strong>in <strong>uncontrolled diabetes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 149 </span></strong></span></span></p>",
      "correct_choice_id": 25597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6406,
      "choices": [
        {
          "id": 25593,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased protein synthesis</span></p>"
        },
        {
          "id": 25594,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycogenesis in muscle</span></p>"
        },
        {
          "id": 25595,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased conversion of fatty acid to Acetyl CoA</span></p>"
        },
        {
          "id": 25596,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased triglyceride level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 45-year-old male with Type 1 diabetes mellitus presents with a blood glucose level greater than 300 mg/dl. In the context of his elevated blood glucose, which of the following metabolic processes continues to occur normally in this patient?</span></p>",
      "unique_key": "Q1579571",
      "question_audio": null,
      "question_video": null,
      "map_id": 29927,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Increased conversion of fatty acid to Acetyl CoA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">In Type 1 diabetes mellitus with significantly elevated blood glucose (&gt;300 mg/dl), insulin deficiency leads to dramatic metabolic alterations. Without insulin, glucose uptake by peripheral tissues is impaired, leading to hyperglycemia. Simultaneously, the body shifts to alternative fuel sources:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Increased fatty acid mobilization from adipose tissue occurs in insulin deficiency. These fatty acids undergo β-oxidation in the liver, resulting in increased conversion to Acetyl CoA.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The excess Acetyl CoA cannot enter the TCA cycle efficiently due to low oxaloacetate availability (diverted to gluconeogenesis), and instead is shunted toward ketogenesis, producing ketone bodies (acetoacetate, β-hydroxybutyrate, and acetone). This leads to diabetic ketoacidosis in uncontrolled Type 1 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased protein synthesis</strong>: Insulin promotes protein synthesis and inhibits protein breakdown. In Type 1 diabetes with insulin deficiency, protein synthesis decreases while proteolysis increases, providing amino acids for gluconeogenesis. This contributes to the catabolic state and muscle wasting seen in poorly controlled diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glycogenesis in muscle</strong>: This process requires both insulin and adequate glucose transport into muscle cells via GLUT4 transporters. Insulin deficiency impairs GLUT4 translocation to the cell membrane, reducing glucose uptake and subsequent glycogen synthesis in muscle tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased triglyceride level</strong> - This is incorrect. In Type 1 diabetes with insulin deficiency, triglyceride levels are not decreased but are typically increased due to impaired clearance of triglyceride-rich lipoproteins due to decreased lipoprotein lipase activity (an insulin-dependent enzyme) This often leads to hypertriglyceridemia, not decreased triglyceride levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In uncontrolled Type 1 diabetes with hyperglycemia, insulin deficiency creates a catabolic state where fat mobilization and fatty acid oxidation are accelerated, leading to increased Acetyl CoA production and ketogenesis. This represents a shift from glucose to fat metabolism. Meanwhile, anabolic processes like protein synthesis and glycogenesis are impaired, highlighting the crucial role of insulin in regulating metabolic pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 149, Lippincott: P 340&nbsp;</span></p>",
      "correct_choice_id": 25595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6419,
      "choices": [
        {
          "id": 25645,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Has sudden onset of symptoms which is relieved after taking insulin </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> </span></span></span></p>"
        },
        {
          "id": 25646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma glucagon level is lower than normal individuals during early disease process</span></span></span></p>"
        },
        {
          "id": 25647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma insulin level is lower than normal individuals during the early disease process</span></span></span></p>"
        },
        {
          "id": 25648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If body weight is reduced, then improvement in glucose tolerance is observed.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old obese male presents with fatigue, increased appetite, thirst, and polyuria, with a negative Rothera&#39;s test. He is diagnosed with type 2 diabetes. Regarding the characteristics of type 2 diabetes, which of the following statements is TRUE?</span></span></span></p>",
      "unique_key": "Q2974621",
      "question_audio": null,
      "question_video": null,
      "map_id": 29931,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) If body weight is reduced, then improvement in glucose tolerance is observed.&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type 2 diabetes mellitus</strong> patients have <strong>impaired glucose tolerance. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is also called as<strong> non-insulin-dependent diabetes (NIDDM)</strong> because of <strong>impaired sensitivity or resistance </strong>of tissues to the<strong> insulin action.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of the patients appear <strong>obese</strong> and show<strong> good improvement in blood glucose (</strong>glucose tolerance) with significant <strong>weight reduction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Has sudden onset of symptoms which is relieved after taking insulin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gradual onset of Symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Plasma glucagon level is lower than normal individuals during early disease process:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glucagon levels are normal.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasma insulin level is lower than normal individuals during the early disease process:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> elevated insulin levels are observed in patients and requires insulin late in the disease. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Weight reduction</strong> through <strong>lifestyle changes</strong> can significantly<strong> improve metabolic</strong> control in individuals with <strong>type 2 diabetes</strong> by <strong>enhancing insulin sensitivity </strong>and <strong>reducing insulin resistance,</strong> underscoring the importance of<strong> non-pharmacological interventions</strong> in the management of the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 185, 192-194.</span></strong></span></span></p>",
      "correct_choice_id": 25648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6158,
      "choices": [
        {
          "id": 24601,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of PFK-II</span></span></span></p>"
        },
        {
          "id": 24602,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of Fructose 2,6 Bisphosphatase</span></span></span></p>"
        },
        {
          "id": 24603,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in glucagon</span></span></span></p>"
        },
        {
          "id": 24604,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in Fructose 2,6 Bisphosphate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a marathon, an endurance athlete experiences a significant drop in blood glucose levels, triggering a series of metabolic adjustments. A sports medicine specialist explaining these changes to the athlete highlights how the body responds to maintain energy balance. Which of the following responses to decreased blood glucose levels is incorrect?</span></span></span><br />\r\n&nbsp;</p>",
      "unique_key": "Q2698138",
      "question_audio": null,
      "question_video": null,
      "map_id": 29929,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Increase in Fructose 2, 6 Bisphosphate</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When <strong>blood glucose levels decrease,</strong> the body <strong>does not</strong> <strong>increase</strong> <strong>fructose 2,6-bisphosphate levels.</strong> Instead, <strong>fructose 2,6-bisphosphate levels</strong> would <strong>decrease </strong>due to the activation of <strong>fructose 2,6-bisphosphatase</strong> and<strong> inhibition of PFK-II. </strong>This adjustment <strong>reduces glycolytic flux</strong> and <strong>promotes gluconeogenesis</strong>, helping to<strong> raise blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inhibition of PFK-II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>correct</strong> response to <strong>low blood glucose levels</strong>, leading to <strong>decreased fructose 2,6-bisphosphate</strong> production and <strong>reduced glycolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Activation of Fructose 2,6 Bisphosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This also accurately <strong>reflects</strong> the body&#39;s response to<strong> low blood glucose,</strong> promoting th<strong>e lowering of fructose 2,6-bisphosphate levels </strong>and encouraging<strong> gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increase in glucagon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glucagon levels increase in <strong>response</strong> to <strong>low blood glucose</strong> to <strong>stimulate gluconeogenesis </strong>and <strong>glycogenolysis</strong>, <strong>raising blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increase Blood Glucose Level</strong>:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Inhibition of Glycolysis</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By phosphorylating the key enzymes of Glycolysis (option a)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Favour Gluconeogenesis</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By phosphorylating Key enzymes of Gluconeogenesis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p191</span></strong></span></span></p>",
      "correct_choice_id": 24604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}